Skip to main content.

Studies Currently Enrolling

KU School of Medicine-Wichita Center for Clinical Research is looking for volunteers to participate in research studies.

Studies may include:

  • time/travel reimbursement
  • medication
  • clinical evaluations
  • medical tests
  • physical exams


View details of current studies:

Pediatrics

  • Research database – Interested in learning more about future clinical trials? Join our research database! The purpose of this database is to collect potential participants’ demographic and personal health information to determine if they qualify for any current and/or future research studies.

Adults

  • Agitation in Alzheimer’s  CCR currently offers multiple studies related to treating the symptoms of agitation in Alzheimer’s disease. Agitation can manifest in several areas, including verbal behaviors such as cursing or excessive complaining, physical behaviors such as restlessness or pacing, and physical aggression such as hitting or hurting self or others. Both studies require participants to have an Alzheimer’s diagnosis, clinically significant agitation and a caregiver who is also willing to participate. Both studies also offer compensation for willing participants.
  • ACTIV-6 COVID-19 treatment – People who test positive for COVID-19 may be eligible for an at-home study. ACTIV-6 is investigating existing medications to learn if they may help people with mild-to-moderate COVID-19 feel better faster and stay out of the hospital. Participants must be at least 30 years old, have tested positive for COVID-19 within 10 days and have at least two symptoms of the illness for seven days or less. Participants will receive by mail either a placebo or a study medication, answer short, daily online surveys for 14-28 days and complete a follow-up survey after 90 days. A gift card of up to $100 will be awarded upon completion of the study. Learn more from the study flyer.
  • Chronic cough – If you have a refractory chronic cough (RCC) that seriously impacts your quality of life and social interactions, CALM-1 wants to help “calm the cough.” The CALM-1 study is looking for participants who are 18-80 years of age, had an RCC for at least a year, and medical evaluations and prescribed and/or over-the-counter treatments have not greatly improved your symptoms. The study will last for up to 52 weeks, with 18 in-clinic visits.
  • Crohn’s disease – The DUET-CD study is being conducted to determine if an investigational medication is safe and effective in individuals with moderately to severely active Crohn’s disease (CD). This study is looking for participants who are 18-65 years of age, have had moderately to severely active CD for at least three months and have not responded to treatment for CD. The study will last for 48 weeks and participants will receive around $100 per visit.
  • Personality disorders – This study is recruiting participants who have personality disorder features, traits or characteristics. These participants must be 18 years or older, have been receiving treatment for a minimum of six months, and understand written and spoken English. Eligible participants will complete questionnaires and provide a saliva sample, which will be sent to 23andMe for analysis. The participants will receive 23andMe results at no charge.
  • Research database – Interested in learning more about future clinical trials? Join our research database! The purpose of this database is to collect potential participants’ demographic and personal health information to determine if they qualify for any current and/or future research studies.
  • Respiratory syncytial virus (RSV) – A five-week study to assess the safety and efficacy of an investigational medication to prevent severe illness in adults with respiratory syncytial virus infection (RSV). Participants will receive a total of 10 doses of the investigational drug or placebo. The study population will include symptomatic participants with confirmed RSV infection who are at increased risk of progression to severe illness.
  • Ulcerative colitis (UC) – An 84-week study to evaluate the efficacy and safety of an investigational medication for the treatment of moderately to severely active ulcerative colitis. Participants must be 18 years or older and have a diagnosis of moderately to severely active UC of at least 12 weeks prior to participating in the study.

In partnership with KU Medical Center in Kansas City, CCR is also participating in the following clinical trials:

  • Alzheimer’s Prevention – Study for adults 40-60 without memory impairment to complete surveys regarding the benefits of diet and exercise for the prevention of Alzheimer’s disease and the effects of menopause on long-term brain health. Surveys are completed online or via telephone and are expected to take 15-30 minutes to complete. Participants will receive $75 upon completion of all surveys. Learn more from the study flyer.
  • Amyotrophic lateral sclerosis (ALS) – The Wilkins Functional Biomarkers for ALS is a multi-center, longitudinal study with no intervention. Biomarkers are essential for treatment response outcomes for ALS and to facilitate treatment efforts. This study is looking for both healthy subjects and subjects who have been diagnosed with ALS. Subject participation will include four clinic visits over an 8–12 month time frame.
  • COPD – RELIANCE is a nationwide study that compares azithromycin and roflumilast to learn if long-term use improves the lives of people with COPD. RELIANCE is looking for participants who are least 40 years of age, have been diagnosed with COPD or hospitalized for COPD in the last 12 months, and are discussing stronger COPD treatment with their doctor.
  • Cohort – The Clinical Cohort Study is working to establish and maintain a group of potential research participants willing to allow us to follow their aging process over time. This is an observational study that will include both healthy participants and participants with Alzheimer's disease. Participation in this study would require yearly visits for as long as the participant is willing and/or able. These visits will include a clinical evaluation, memory evaluation and additional optional assessments.
person taking notes on a clipboard

Ready to participate or have questions?

Contact us at 316-293-1833 or complete the online interest form:
Complete the Clinical Trials Interest Form
KU School of Medicine-Wichita

1010 North Kansas
Wichita, KS 67214-3199
316-293-2635